Annual Shareholders Equity
$121.19 M
-$49.28 M-28.91%
December 31, 2023
Summary
- As of February 8, 2025, ACRV annual stockholders equity is $121.19 million, with the most recent change of -$49.28 million (-28.91%) on December 31, 2023.
- During the last 3 years, ACRV annual shareholders equity has risen by +$129.61 million (+1540.57%).
- ACRV annual shareholders equity is now -28.91% below its all-time high of $170.47 million, reached on December 31, 2022.
Performance
ACRV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$196.89 M
-$19.17 M-8.87%
September 30, 2024
Summary
- As of February 8, 2025, ACRV quarterly stockholders equity is $196.89 million, with the most recent change of -$19.17 million (-8.87%) on September 30, 2024.
- Over the past year, ACRV quarterly shareholders equity has increased by +$58.74 million (+42.52%).
- ACRV quarterly shareholders equity is now -8.87% below its all-time high of $216.06 million, reached on June 30, 2024.
Performance
ACRV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACRV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.9% | +42.5% |
| 3 y3 years | +1540.6% | +42.5% |
| 5 y5 years | +1540.6% | +42.5% |
ACRV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.9% | +609.0% | -8.9% | +531.6% |
| 5 y | 5-year | -28.9% | +609.0% | -8.9% | +531.6% |
| alltime | all time | -28.9% | +609.0% | -8.9% | +531.6% |
Acrivon Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $196.89 M(-8.9%) |
| Jun 2024 | - | $216.06 M(+100.1%) |
| Mar 2024 | - | $107.98 M(-10.9%) |
| Dec 2023 | $121.19 M | $121.19 M(-12.3%) |
| Sep 2023 | - | $138.15 M(-7.4%) |
| Jun 2023 | - | $149.18 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $160.47 M(-5.9%) |
| Dec 2022 | $170.47 M(-816.0%) | $170.47 M(-473.7%) |
| Sep 2022 | - | -$45.62 M(+24.7%) |
| Jun 2022 | - | -$36.58 M(+53.6%) |
| Dec 2021 | -$23.81 M(+183.0%) | - |
| Dec 2021 | - | -$23.81 M |
| Dec 2020 | -$8.41 M | - |
FAQ
- What is Acrivon Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual shareholders equity year-on-year change?
- What is Acrivon Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly shareholders equity year-on-year change?
What is Acrivon Therapeutics annual stockholders equity?
The current annual shareholders equity of ACRV is $121.19 M
What is the all time high annual shareholders equity for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual stockholders equity is $170.47 M
What is Acrivon Therapeutics annual shareholders equity year-on-year change?
Over the past year, ACRV annual stockholders equity has changed by -$49.28 M (-28.91%)
What is Acrivon Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ACRV is $196.89 M
What is the all time high quarterly shareholders equity for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly stockholders equity is $216.06 M
What is Acrivon Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ACRV quarterly stockholders equity has changed by +$58.74 M (+42.52%)